Published in Gene Therapy Weekly, February 20th, 2003
"However, the use of lentiviral-based vectors in the clinic also raises specific safety and ethical issues," warned J. B. Connolly and colleagues at the Department of Health's Gene Therapy Advisory Committee.
"Concerns include the possible generation of replication competent lentiviruses during...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly